Trupanion (TRUP) to Release Earnings on Wednesday

Trupanion (NASDAQ:TRUP) is expected to post its quarterly earnings results after the market closes on Wednesday, February 19th. Analysts expect Trupanion to post earnings of $0.06 per share and revenue of $335.41 million for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Trupanion Stock Performance

NASDAQ TRUP opened at $49.63 on Monday. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40. The business’s 50 day moving average is $48.78 and its two-hundred day moving average is $47.77. Trupanion has a 12-month low of $19.69 and a 12-month high of $57.90. The stock has a market capitalization of $2.10 billion, a price-to-earnings ratio of -155.09, a PEG ratio of 8.03 and a beta of 1.60.

Insider Buying and Selling

In related news, CFO Fawwad Qureshi sold 9,867 shares of the company’s stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $53.08, for a total value of $523,740.36. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Steve Weinrauch sold 11,916 shares of the company’s stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $53.00, for a total value of $631,548.00. Following the completion of the sale, the executive vice president now directly owns 48,978 shares in the company, valued at approximately $2,595,834. The trade was a 19.57 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 26,597 shares of company stock worth $1,416,742 in the last quarter. Company insiders own 5.50% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the company. Northland Securities boosted their target price on Trupanion from $45.00 to $50.00 and gave the stock a “market perform” rating in a research report on Thursday, October 31st. Stifel Nicolaus upped their price target on Trupanion from $42.00 to $44.00 and gave the stock a “hold” rating in a report on Monday, January 6th. Finally, Piper Sandler upgraded Trupanion from a “neutral” rating to an “overweight” rating and set a $57.00 price target on the stock in a report on Thursday, January 23rd. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, Trupanion has an average rating of “Moderate Buy” and an average price target of $45.33.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.